Advertisement

Intrapartum hepatitis B screening

  • Scott Petermann
    Affiliations
    Department of Obstetrics and Gynecology, Bowman Gray School of Medicine of Wake Forest University Winston-Salem, North Carolina, USA
    Search for articles by this author
  • J.M. Ernest
    Correspondence
    Reprint requests: J.M. Ernst, MD, Department of Obstetrics and Gynecology, Bowman Gray School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1066.
    Affiliations
    Department of Obstetrics and Gynecology, Bowman Gray School of Medicine of Wake Forest University Winston-Salem, North Carolina, USA
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      OBJECTIVE: The purpose of this study was to determine the prevalence of acute hepatitis B in intrapartum patients and to describe the birth-to-administration interval of the hepatitis B vaccine and immune globulin in hepatitis B surface antigen-positive patients detected by intrapartum screening.
      STUDY DESIGN: Hepatitis B screening was performed on 8712 laboring patients admitted to Forsyth Memorial Hospital in Winston-Salem, North Carolina, between July 1, 1992, and Jan. 31, 1994.
      RESULTS: Fourteen laboring patients had positive results for hepatitis B surface antigen (prevalence 0.16%), and two of the 14 had a profile consistent with acute disease. The average interval from birth to administration of the hepatitis B immune globulin and hepatitis B virus vaccine was 18.6 hours (range 3.9 to 31.0 hours) for hepatitis B virus-infected patients whose hepatitis B surface antigen status was unknown before labor.
      CONCLUSION: Intrapartum screening allows for diagnosis of the asymptomatic patient with acute hepatitis B virus infection whose hepatitis B surface antigen status was unknown before labor who would not have received hepatitis B immune globulin had only early prenatal screening been performed.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Centers for Disease Control
        Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee (ACIP).
        MMWR Morb Mortal Wkly Rep. 1991; 40: 1-25
        • Beasley RP
        • Lee GC-Y
        • Roan C-H
        • et al.
        Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine.
        Lancet. 1983; 2: 1099-1102
        • Wong VCW
        • Reesink HW
        • Ip HM
        • et al.
        Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin.
        Lancet. 1984; 1: 921-926
        • Stevens CE
        • Taylor PE
        • Tong MJ
        • et al.
        Yeast-recombinant hepatitis B vaccine: efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission.
        JAMA. 1987; 257: 2612-2616
        • American College of Obstetricians and Gynecologists.Committee on Obstetrics:
        • Maternal and Fetal Medicine
        Guidelines for hepatitis B virus screening and vaccination during pregnancy.
        Int J Gynecol Obstet. 1993; 40: 172-174
        • Ernest JM
        • Givner LB
        • Pool R
        Intrapartum hepatitis B screening in a low-risk population.
        Am J Obstet Gynecol. 1990; 163: 978-980
        • Eble K
        • Clemens J
        • Krenc C
        • et al.
        Differential diagnosis of acute viral hepatitis using rapid, fully automated immunoassays.
        J Med Virol. 1991; 33: 139-150
        • Okada K
        • Kamiyama I
        • Inomata M
        • Imai M
        • Miyakawa Y
        • Mayumi M
        e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B to their infants.
        N Engl J Med. 1976; 294: 746-749
        • Beasley RP
        • Trepo C
        • Stevens CE
        • Szmuness W
        The e antigen and vertical transmission of hepatitis B surface antigen.
        Am J Epidemiol. 1977; 105: 94-98
        • Centers for Disease Control
        Protection against viral hepatitis: recommendations of the Immunization Practices Advsory Committee (ACIP).
        MMWR Morb Mortal Wkly Rep. 1990; 39: 1-26
        • Overby LR
        • Ling CM
        • Decker RH
        • Mushahwar IK
        • Chau KH
        Serodiagnostic profiles in viral hepatitis.
        in: Szmuness W Alter HJ Maynard JE Viral hepatitis. Franklin Institute Press, Philadelphia1981: 169-181
        • Kryger P
        • Aldershvile J
        • Mathiesen LR
        • Nielsen JD
        Copenhagen. Hepatitis Acuta Programme. Acute type B hepatitis among HBsAg negative patients detected by anti-HBc IgM. 4th ed. Hepatology. 2. 1982: 50-53
        • Mortimer PP
        • Vandervelde EM
        • Parry JV
        • Cohen BJ
        • Tedder RS
        The anti-HBc IgM response in acute and convalescent phases of acute hepatitis.
        J Infect. 1981; 3: 339-347
        • Hansson BG
        Persistence of serum antibody to hepatitis B core antigen.
        J Clin Microbiol. 1977; 6: 209-211
        • Hoofnagle JH
        • Gerety RJ
        • Barker LF
        Antibody to hepatitis B virus core in man.
        Lancet. 1973; 2: 869-873
        • Hawkes RA
        • Boughton CR
        • Ferguson V
        • Lehmann NI
        Use of immunoglobulin M antibody to hepatitis B core antigen in diagnosis of viral hepatitis.
        J Clin Microbiol. 1980; 11: 581-583
        • Roggendorf M
        • Deinhardt F
        • Frosner GG
        • Scheid R
        • Bayer LB
        • Zachoval R
        Immunoglobulin M antibodies to hepatitis B core antigen: evaluation of enzyme immunoassay for diagnosis of hepatitis B virus infection.
        J Clin Microbiol. 1981; 13: 618-626
        • Lemon SM
        • Gates NL
        • Simms TE
        • Bancroft WH
        IgM antibody to hepatitis B core antigen as a diagnostic parameter of acute infection with hepatitis B virus.
        J Infect Dis. 1981; 143: 803-809
        • Chau KH
        • Hargie MP
        • Decker RH
        • Mushahwar IK
        • Overby LR
        Serodiagnosis of recent hepatitis B infection by IgM class anti-HBc.
        Hepatology. 1983; 3: 142-149
        • Kryger P
        Significance of anti-HBc IgM in the differential diagnosis of viral hepatitis.
        J Virol Methods. 1985; 10: 283-289
        • Govindarajan S
        • Ashcavai M
        • Chau KH
        • Nevalainen DE
        • Peters RL
        Evaluation of enzyme immunoassay for anti-HBc IgM in the diagnosis of acute hepatitis B virus infection.
        Am J Clin Pathol. 1984; 82: 323-325
        • Beasley RP
        • Hwang L-Y
        Epidemiology of hepatocellular carcinoma.
        in: Vyas GN Dienstag JL Hoofnagle JH Viral hepatitis and liver disease. Grune & Stratton, New York1984: 209-224
        • Beasley RP
        • Stevens CE
        Vertical transmission of HBV and interruption with globulin.
        in: Vyas GN Cohen SN Schmid R Viral hepatitis. Franklin Institute Press, Philadelphia1978: 333-345
        • Okuda N
        Prevention of perinatally acquired hepatitis B infection.
        Hokkaido Med J. 1982; 57: 151-156
        • Beasley RP
        • Lin C-C
        • Wang K-Y
        • et al.
        Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state.
        Lancet. 1981; 2: 388-393
        • Xu Z-Y
        • Liu C-B
        • Francis DP
        • et al.
        Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: preliminary report of a randomized, double-blind placebo-controlled and comparative trial.
        Pediatrics. 1985; 76: 713-718

      References

        • Koretz L
        Universal prenatal hepatitis B testing: is it cost-effective?.
        Obstet Gynecol. 1989; 74: 808-814
        • Baker DA
        Hepatitis B infection in pregnancy.
        in: Mead PB Hager WD Infection protocols for obstetrics and gynecology. Medical Economics, Montvale, New Jersey1992: 125-130
        • Simms J
        • Duff P
        Viral hepatitis in pregnancy.
        Semin Perinatol. 1993; 17: 384-393
        • Centers for Disease Control and Prevention
        Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee (ACIP).
        MMWR Morb Mortal Wkly Rep. 1991; 40: 1-25
        • Centers for Disease Control and Prevention
        Maternal hepatitis B screening practices—California, Connecticut, Kansas, and United States, 1992–1993.
        MMWR Morb Mortal Wkly Rep. 1994; 43: 311-320
        • American College of Obstetricians and Gynecologists
        Guidelines for hepatitis B virus screening and vaccination during pregnancy.
        American College of Obstetricians and Gynecologists, Washington1992 (ACOG Committee Opinion no 111)
        • American College of Obstetricians and Gynecologists
        Hepatitis in pregnancy.
        in: 4th ed. ACOG Technical Bulletin no 174. American College of Obstetricians and Gynecologists, Washington1992: 1-10